InsidersTradesSigma
Discover the full management transaction log of 아이오바이오, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 아이오바이오 has published 7 insider filings. The latest transaction was disclosed on 5 September 2025 (Other). Among the most active insiders: 에버그린투자파트너스. The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
7 of 7 declarations